Harvard and Stanford become new reference centres for Q-Sense in the US

Thursday, November 23, 2000

Harvard and Stanford becomes new reference centers for Q-Sense in the US

Q-Sense continues to expand its activities in the US and has reached agreements with the universities of Harvard and Stanford as new reference centers in the US. This enables two of the world leading academic institutions and a number of opinion leading scientists to use and participate in the further development of the QCM-D technique.

"This is a major step for Q-Sense and an important bench-mark in the acceptance of the QCM-D technology as a primary tool in a wide area of research applications", says Eva-Carin Tengberg, CEO of Q-Sense AB.

"In order to spread the word about the QCM-D technology we need objective, prominent people communicating to the market about the advantages and possibilities of the technology and our research instrument. To secure this process Q-Sense has so far this year made written agreements with seven prominent academic research groups in Uppsala, Helsinki, Zurich, Bordeaux, Strasbourg and now also Harvard and Stanford", continues Eva-Carin Tengberg.

Q-Sense AB, located in Gothenburg, Sweden was founded in 1996 on the basis of the patented technique, QCM-D. Up to 1999 focus was on technology and product development and early this year the company entered into a commercial phase and has since then, successfully sold over a dozen research instruments worldwide.

QCM-D Technology
The QCM-D technique determines the mass of very thin surface bound layers and simultaneously gives information about their viscoelastic properties. This offers new opportunities to study conformational changes in layers formed on the sensor surface. Moreover, the QCM-D technology includes water coupled to hydrated layers in measurements, in contrast to the optical mass, obtained from methods such as surface plasmon resonance (SPR) and ellipsometry. These unique properties make QCM-D an invaluable tool for studying macromolecules at surfaces and an important complement to existing biosensor technologies.

Applications include research within drug discovery, drug development, biofouling, biomaterials and surfactants.

For further information:
Eva-Carin Tengberg, CEO, Q-Sense AB, Phone: +46 31 772 80 44, Mobile: +46 70 888 81 35